336-340https://jddonline.com/articles/use-of-apremilast-in-patients-who-are-dissatisfied-with-stable-maintenance-topical-therapy-S1545961619P0336X/其它外文期刊

阿普米司特（Apremilast，商品名：Otezla）于2014年获FDA批准，用于治疗银屑病关节炎，自此便开启了银屑病治疗新格局。2022年7月，FDA批准了PDE4抑制剂Zoryve（Roflumilast）乳剂上市，用于...

1224-6.https://jddonline.com/articles/apremilast-for-discoid-lupus-erythematosus-results-of-a-phase-2-open-label-single-arm-pilot-study-S1545961612P1224X/

ManHW,SchaferP,WongLMDiscoveryof(S)-N-[2-[1-(3-ethoxy-4-methoxyphenyl)-2-methanesulfonylethyl]-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl]acetamide(apremilast),...

求汤森路透报告。cas:608141-41-9药品名称：Apremilast谢谢。

GillianM.KeatingApremilast:AReviewinPsoriasisandPsoriaticArthritisAdisDrugEvaluation201777（4），459–472SpringerLink

economicalprocessforpreparationofapremilastandidentifiedtheirimpuritiesinfo'.2.'][info3]AsianJournalofChemistryinfo'.3.'][info4]2016info'.4.'][info5]vol.28,#...

EffectivenessofApremilastforTreatingActivePsoriaticArthritis:ACritiqueoftheEvidence.info'.2.'][info3]Pharmacoeconomics.info'.3.'][info4]2016Novinfo'.4.'][info...

apremilastfortreatingpsoriaticarthritis.info'.2.'][info3]Expertopinionondrugsafetyinfo'.3.'][info4]2015info'.4.'][info5]14(6):979-985.info'.5.'][info6]10.1517/...

patternsofplaquepsoriasispatientsnewlyinitiatedonapremilastoretanercepttherapyAvailableonline31May2017info'.2.'][info3]Elsevierinfo'.3.'][info4]2017info'...

Apremilast[info1]Lee,PhilipWinfo'.1.'][info2]Apremilastinfo'.2.'][info3]HandbookofMetabolicPathwaysofXenobioticsinfo'.3.'][info4]2014info'.4.'][info5]Volume3...

(Apremilast),aPotentandOrallyActivePhosphodiesterase4andTumorNecrosisFactor-αInhibitorinfo'.2.'][info3]J.Med.Cheminfo'.3.'][info4]2009info'.4.'][info5]52(6),...

(Apremilast),aPotentandOrallyActivePhosphodiesterase4andTumorNecrosisFactor-αInhibitorinfo'.2.'][info3]J.Med.Chem.,2009,52(6),pp1522–1524info'.3.'][info4]J....

(Apremilast),aPotentandOrallyActivePhosphodiesterase4andTumorNecrosisFactor-αInhibitorinfo'.2.'][info3]JournalofMedicinalChemistryinfo'.3.'][info4]2009info...

ElnazMenhaji-Klotz,andThomasA.Chappie4.1Introduction454.2BriefSummaryofpan-PDE4Inhibitors464.2.1Rolipram474.2.2Roflumilast484.2.3Cilomilast484.2.4Apremilast494.3PDE4...

apremilastinfo'.2.'][info3]ExpertReviewofClinicalImmunologyinfo'.3.'][info4]2016info'.4.'][info5]Volume12,Issue3,2016info'.5.'][info6]DOI:10.1586/1744666X.2016....

[info1]PooleRM1,BallantyneAD.info'.1.'][info2]Apremilast:firstglobalapproval.info'.2.'][info3]Drugs.info'.3.'][info4]2014info'.4.'][info5]2014May;74(7):825-37...

ChristopherEdwardsc&AlvinWellsdinfo'.1.'][info2]Apremilast:aPDE4inhibitorforthetreatmentofpsoriaticarthritisinfo'.2.'][info3]ExpertOpiniononPharmacotherapy...

Chiricozzi,Andreainfo'.1.'][info2]Apremilastforthetreatmentofpsoriasisinfo'.2.'][info3]FromExpertOpiniononPharmacotherapyinfo'.3.'][info4]2015info'.4.'][info5...

[info1]Birdinfo'.1.'][info2]APREMILAST,ANORALPHOSPHODIESTERASE4INHIBITOR,INPATIENTSWITHPSORIATICARTHRITIS:RESULTSOFPHASE3,RANDOMIZED,PLACEBO-CONTROLLEDTRIALS...

[info1]FitzGeraldOliverinfo'.1.'][info2]Spondyloarthropathies:Apremilast:welcomeadvanceintreatmentofpsoriaticarthritisinfo'.2.'][info3]Naturereviews.Rheumatology...

treatedwithanoralantiinflammatoryagent,apremilastinfo'.2.'][info3]CurrMedResOpininfo'.3.'][info4]2008info'.4.'][info5]24(5):1529-1538info'.5.']

(Apremilast),apotentandorallyactivephosphodiesterase4andtumornecrosisfactor-ainhibitorinfo'.2.'][info3]JournalofMedicinalChemistryinfo'.3.'][info4]2009info'...

[info1]RaewynM.Poole,AnitaD.Ballantyneinfo'.1.'][info2]Apremilast:FirstGlobalApprovalinfo'.2.'][info3]Drugsinfo'.3.'][info4]2014info'.4.'][info5]May2014,Volume...

[info1]ByDeeks,EmmaD.info'.1.'][info2]Apremilast:AReviewinPsoriasisandPsoriaticArthritisinfo'.2.'][info3]FromDrugsinfo'.3.'][info4]2015info'.4.'][info5]75(12)...